Establishing surrogate markers of angiogenesis in pediatric oncology phase I and II clinical trials: A Children’s Oncology Group study
|
Hospital for Sick Children / Sylvain Baruchel, MD |
Innovation Grants |
2007 |
Ontario |
Deciphering the Mechanisms of Medulloblastoma Treatment Resistance using Integrative Genomics |
Hospital for Sick Children / Vijay Ramaswamy, MD |
Young Investigator Grants |
2014 |
Ontario |
To test the feasibility, acceptability and effectiveness of a sleep hygiene and relaxation intervention to improve sleep and fatigue for children receiving maintenance therapy for acute lymphoblastic leukemia |
Hospital for Sick Children / Sue Zupanec |
Nurse Researcher Grants |
2010 |
Ontario |
Dissecting Pediatric Brain Tumour Progression Using Single-nuclei Sequencing |
University Health Network / Trevor Pugh, PhD |
Single-cell Pediatric Cancer Atlas Grant |
2019 |
Ontario |
Nuclear Receptor Tyrosine Kinases Mediating Chromatin Remodeling & Checkpoint Adaption |
Children’s Cancer Therapy Development Institute / Charles Keller, MD |
Innovation Grants |
2018 |
Oregon |
Moving EphB4 Therapeutics to Pediatric Phase I/II Trials |
Oregon Health & Science University / Charles Keller, MD |
Reach Grants |
2013 |
Oregon |
Therapeutics In Ovo
|
Oregon Health & Science University / Charles Keller |
Innovation Grants |
2008 |
Oregon |
Pediatric Oncology Investigational Therapeutics.
|
Doernbecher Children’s Hospital Foundation / Linda Stork, MD |
Phase I/II Infrastructure Grants |
2007 |
Oregon |
Role of Inflammatory Microenvironment in Clonal evolution and Progression from FPD to AML |
Oregon Health & Science University / Anupriya Agarwal, PhD |
RARE Grant Program (Research Accelerating RUNX1 Exploration) |
2017 |
Oregon |
In-UTR mutations in neuroblastoma: Functional consequences and therapeutic implications |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD |
Innovation Grants |
2012 |
Pennsylvania |